Therapeutic potential of anti-miR29a in breast cancer patients with type 2 diabetes: an in vitro and xenograft mouse-model study

BACKGROUND: MicroRNAs (miRNAs) acting as tumour suppressors or oncogenes, known as oncomiRs, are a promising new focus in targeted therapies for cancer. Approximately 16% of breast cancer patients have pre-existing diabetes. Breast cancer with type 2 diabetes mellitus (BDM) is provided with its uniq...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Zhihua, Min, Liangliang, Chen, Lu, Hu, Yangyang, Luan, Wenjing, Li, Cong, Xiong, Qiuyun, Huang, Kedi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9189168/
https://www.ncbi.nlm.nih.gov/pubmed/35706821
http://dx.doi.org/10.21037/tcr-22-824

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9189168/
https://www.ncbi.nlm.nih.gov/pubmed/35706821
http://dx.doi.org/10.21037/tcr-22-824

Ejemplares similares